{"id":"https://openalex.org/W1992094129","doi":"https://doi.org/10.1038/sj.bjp.0700971","title":"The effects of spiradoline (U\u201062066E), a \u03ba\u2010opioid receptor agonist, on neuroendocrine function in man","display_name":"The effects of spiradoline (U\u201062066E), a \u03ba\u2010opioid receptor agonist, on neuroendocrine function in man","alternate_titles":[],"publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W1992094129","doi":"https://doi.org/10.1038/sj.bjp.0700971","mag":"1992094129","pmid":"https://pubmed.ncbi.nlm.nih.gov/9138682","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564535"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0700971","doi":"https://doi.org/10.1038/sj.bjp.0700971","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0700971","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0700971","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992094129"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0700971","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109927354","display_name":"Ehud Ur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130438778","display_name":"Memorial University of Newfoundland","ror":"https://ror.org/04haebc03","country_code":"CA","type":"education","lineage":["https://openalex.org/I130438778"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ehud Ur","raw_affiliation_strings":["Division of Endocrinology, Memorial University of Newfoundland, St John's, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Memorial University of Newfoundland, St John's, Canada","institution_ids":["https://openalex.org/I130438778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113520610","display_name":"D.M. Wright","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Mark Wright","raw_affiliation_strings":["Upjohn Laboratories - Europe, Upjohn Limited, Fleming Way, Crawley, West Sussex RH10 2NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Upjohn Laboratories - Europe, Upjohn Limited, Fleming Way, Crawley, West Sussex RH10 2NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105003642","display_name":"Pierre Marc Bouloux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierre M G Bouloux","raw_affiliation_strings":["Royal Free Hospital, Pond St, London NW3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Free Hospital, Pond St, London NW3","institution_ids":["https://openalex.org/I2801138448"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046852415","display_name":"Ashley Barry Grossman","orcid":"https://orcid.org/0000-0003-1176-6186","observed_orcids":["https://orcid.org/0000-0003-1176-6186"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ashley Grossman","raw_affiliation_strings":["St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K","institution_ids":["https://openalex.org/I1307195382"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5109927354"],"corresponding_institution_ids":["https://openalex.org/I130438778"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.7815,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.65184977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"120","issue":"5","first_page":"781","last_page":"784"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10960","display_name":"Hypothalamic control of reproductive hormones","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spiradoline","display_name":"spiradoline","score":0.9869999885559082},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.9300000071525574},{"id":"https://openalex.org/keywords/neuroendocrine-effects","display_name":"neuroendocrine effects","score":0.878000020980835},{"id":"https://openalex.org/keywords/prolactin-secretion","display_name":"prolactin secretion","score":0.8119999766349792},{"id":"https://openalex.org/keywords/growth-hormone-secretion","display_name":"growth hormone secretion","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cortisol-secretion","display_name":"cortisol secretion","score":0.9620000123977661},{"id":"https://openalex.org/keywords/free-water-clearance","display_name":"free water clearance","score":0.9620000123977661},{"id":"https://openalex.org/keywords/catecholamines","display_name":"catecholamines","score":0.953000009059906},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.6439999938011169},{"id":"https://openalex.org/keywords/dose-dependence","display_name":"dose dependence","score":0.36800000071525574},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6931178569793701},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.6805734634399414},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.653304934501648},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6468796730041504},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5517675876617432},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.5069537162780762},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.5042089223861694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48504751920700073},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4709552228450775},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3384547829627991},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.26199090480804443},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002395","descriptor_name":"Catecholamines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004644","descriptor_name":"Emotions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009490","descriptor_name":"Neurosecretory Systems","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009490","descriptor_name":"Neurosecretory Systems","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjp.0700971","doi":"https://doi.org/10.1038/sj.bjp.0700971","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0700971","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0700971","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3469396","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564535","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1564535","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1564535/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:9138682","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9138682","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0700971","doi":"https://doi.org/10.1038/sj.bjp.0700971","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0700971","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0700971","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1992094129.pdf","grobid_xml":"https://content.openalex.org/works/W1992094129.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W49232572","https://openalex.org/W1927977357","https://openalex.org/W1971547791","https://openalex.org/W1977834805","https://openalex.org/W1983337012","https://openalex.org/W1983405690","https://openalex.org/W1983833328","https://openalex.org/W1988000035","https://openalex.org/W1988605143","https://openalex.org/W2004386263","https://openalex.org/W2011645297","https://openalex.org/W2023830317","https://openalex.org/W2024285133","https://openalex.org/W2034656049","https://openalex.org/W2059512977","https://openalex.org/W2068823810","https://openalex.org/W2075977089","https://openalex.org/W2077696843","https://openalex.org/W2081741081","https://openalex.org/W2146584661","https://openalex.org/W2169564578","https://openalex.org/W2260450502","https://openalex.org/W2260534049","https://openalex.org/W2327298537"],"related_works":["https://openalex.org/W2145182954","https://openalex.org/W2086183145","https://openalex.org/W1987782437","https://openalex.org/W2408069397","https://openalex.org/W2023830317","https://openalex.org/W2558360039","https://openalex.org/W2062530266","https://openalex.org/W2137242509","https://openalex.org/W2295941813","https://openalex.org/W2088689677"],"abstract_inverted_index":{"1.":[0],"Opioid":[1],"drugs":[2],"act":[3],"on":[4],"specific":[5],"receptors":[6],"which":[7,23],"are":[8],"principally":[9],"classified":[10],"into":[11],"mu,":[12],"delta":[13],"and":[14,56,91,108,121,132,140,196,228,236,243],"kappa":[15],"subtypes.":[16],"Spiradoline":[17,160],"(U-62066E)":[18],"is":[19],"a":[20,75,162,176,182],"kappa-selective":[21],"agent":[22],"has":[24],"been":[25],"shown":[26],"to":[27,241],"possess":[28],"potent":[29],"anti-nociceptive":[30],"effects":[31,46],"but":[32],"does":[33],"not":[34],"show":[35],"cross":[36],"tolerance":[37],"with":[38,52],"morphine.":[39],"2.":[40],"We":[41,219],"have":[42,220],"assessed":[43,114],"the":[44,62,116,122,130,232],"neuroendocrine":[45],"of":[47,61,74,101,157,185,234],"spiradoline":[48],"in":[49,169,209,231,252],"healthy":[50],"volunteers":[51],"two":[53],"doses":[54],"(1.6":[55],"4.0":[57],"micrograms":[58],"kg-1,":[59],"i.m.)":[60],"compound.":[63],"Six":[64],"male":[65],"non-smokers":[66],"aged":[67],"19-27":[68],"years":[69],"were":[70,146,153,204],"studied":[71],"by":[72,115,155],"use":[73],"randomized,":[76],"double-blind":[77],"three-limb":[78],"placebo-controlled":[79],"cross-over":[80],"design.":[81],"Blood":[82],"was":[83,113],"taken":[84],"from":[85],"an":[86],"in-dwelling":[87],"venous":[88],"cannula":[89],"basally":[90],"at":[92,133,148],"15":[93],"min":[94,139,150],"intervals":[95],"for":[96,99,175,190],"2":[97,141],"h":[98,137,142],"determination":[100],"serum":[102],"cortisol,":[103],"prolactin,":[104,186],"growth":[105],"hormone":[106],"(GH)":[107],"catecholamines.":[109],"3.":[110],"Psychological":[111],"function":[112],"Stanford":[117],"Sleepiness":[118],"Scale":[119],"(SSS)":[120],"Addiction":[123],"Research":[124],"Centre":[125],"Inventory":[126],"(ARCI)":[127],"administered":[128],"before":[129],"medication":[131],"35":[134],"min,":[135],"1":[136],"25":[138],"afterwards.":[143],"Cardiovascular":[144],"variables":[145],"recorded":[147],"10":[149],"intervals.":[151],"Results":[152],"analysed":[154],"analysis":[156],"variance.":[158],"4.":[159],"showed":[161],"significant":[163,206],"(P":[164,200],"<":[165,201],"0.05)":[166],"dose-dependent":[167,183],"increase":[168,225],"free":[170],"water":[171],"clearance,":[172],"as":[173],"predicted":[174],"kappa-opioid":[177],"agonist.":[178],"It":[179],"also":[180],"caused":[181],"stimulation":[184,233],"(increment":[187],"over":[188],"baseline":[189],"higher":[191],"dose":[192],"214%),":[193],"GH":[194,237],"(433%)":[195],"cortisol":[197,250],"(215%)":[198],"release":[199,251],"0.05).":[202],"There":[203],"no":[205],"drug-related":[207],"changes":[208],"plasma":[210],"catecholamines,":[211],"blood":[212],"pressure,":[213],"pulse":[214],"or":[215],"psychological":[216],"variables.":[217],"5.":[218],"therefore":[221],"confirmed":[222],"that":[223],"kappa-opioids":[224],"free-water":[226],"clearance":[227],"may":[229],"participate":[230],"prolactin":[235],"release.":[238],"In":[239],"contrast":[240],"mu":[242],"delta-opioid":[244],"agonists,":[245],"this":[246],"novel":[247],"kappa-agonist":[248],"stimulates":[249],"man.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992094129","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
